The six genes found to be highly significant for prognosis in IDH mutant patients included: cell division cycle (CDC) 20, Wiskott–Aldrich syndrome protein family (WASF)3, deleted in breast cancer (DBC)1, engrailed (EN)2, vimentin (VIM), and carboxypeptidase (CPE). This evidence concerns the gene IDH2 and cancer.